Hind Copper On CNBC-TV18:

Output Was At 9.68 Lk Tonne For Q1, 4.7 mt Core Production Target For FY27

Metal In Concentrate (MIC) Target For FY27 Is 32,000 Tonnes

Our Current EBIDTA Is 55% At Current LME Prices

Even At 45% Of Current LME Prices We Cover Costs

EBITDA Margin Expected To Be In The Range Of 54-55% For FY27

Managed To Squeeze Timelines For Capex

Godrej Consumer Products shares have fallen over 10% at market open a day after the company announced that ots MD and CEO Sudhir Sitapati had resigned with Aasif Malbari taking over the position today for a tenure of 5 years. The company’s shares have fallen over 25% since the beginning of the year and almost 23% in the past year. The stock hit its 52-week low of ₹922.50 at intraday trading today.

National Aluminium Co Ltd shares have risen over 8% at market open. The company’s shares have risen 33% since the beginning of the year and over 124% in the past year. The stock is at a 6% decline from its 52-week high of ₹445.15 and 128% away from hitting its 52-week low of ₹183.86.

Finolex Cables shares have risen over 13% at market open after the company announced strong June-quarter results with its net profit rising 53% from to Rs249crore from Rs162.6 crore (YoY). The company’s shares have risen 74% since the beginning of the year and 62% in the past year. The stock hit its 52-week high of ₹1369.90 at intraday trading today.

Bata, Man Industries shares gain on Q1 results, while Senco falls over 8% on weak Q1 earnings impact

The stock is up over 12% at the moment. It is also the top Nifty 500 gainer in the first hour of trade.

Bata India shares rise over 7% at market open after the company reported consolidated net profit rising 23.1% YoY to ₹64 crore from ₹52 crore, with revenue up 3.9% to ₹979 crore and EBITDA up 2.6% to ₹204 crore. The company’s shares have fallen almsot 21% since the beginning of the year and almost 34% in the past year. The stock is at a 71% decline from its 52-week high of ₹1,282.50 and about 24% away from hitting its 52-week low of ₹605.

Tenecco Large Trade | 3.2 Cr Shares (7.9% Eq) Worth Rs 1,699 Cr Change Hands At Rs 529/sh Via Block

Dr Agarwal’s Large Trade | 4.07 Cr Shares (12.9% Eq) Worth Rs 2065 Cr Change Hands At Rs 506.5/sh Via Block Deals

Market opens flat, all major indices in the red

Abhijit Akella, Kotak Instl Equities On CNBC-TV18

• There Has Been A Sharp Price Inflation
• Companies Were Sitting On Low Cost Inventory Ahead Of Q1
• Strong Q1 Performance Is Not Sustainable For A Long Time
• Deepak Nitrite’s Very High Phenol Spreads In Q1 Should Not Be Extrapolated
• Navin Fluorine Has Been Reporting Strong Numbers In Last Few Quarters
• Navin Fluorine’s Refrigerant Business Is Doing Well
• Pharma CDMO Biz For Navin Fluorine Has Been Ramping Up Well
• 2 Tailwinds For Navin Flourine, But Valn Multiples For Both Tailwinds Are Capped
• Terminal Value To Expected Growth Areas Of Navin Flourine Is Going To Be Low
• Market Has Been In A Mood To Reward Earnings Visibility For Chemical Names
• Acutaas Offers Near-term Earnings Visibility, Hence Rewarded By Markets
• SRF’s Specialty Chemicals Business Has Not Been Doing Well
• Like Jubilant Ingrevia, Trades At Attractive Valuations & Has A Promising CDMO Story
• We Like Jubilant Ingrevia, Godrej Agrovet (Oil Palm Is A Hidden Gem), SH Kelkar & Clean Science
• Godrej Agrovet Is An Interesting Bet, Valn Has Come Off, Business Is Getting Healthier

Sources Say:

N Chandra Weighs Exit From Tata Group As Uncertainty Looms

July 2025 Resolution On Extension Of His Chairmanship Had Set Two Conditions For Renewal

Feb Meet Deferred Renewal & Took Up The Turnaround Of 5 Tata Cos Incl Air India, Tata Digital

Resignation May Be An Option Amid No Quorum On His Reappointment As Director

ACME Solar | Completes Full Redemption Of Offshore Dollar Bonds Through Domestic Refinancing

Rupee Opens At 95.40/$ Vs Tuesday’s Close Of 95.44/$

Pramod Patwari, Balrampur Chini On CNBC-TV18

• Have Not Heard From Govt On Restricting Sugarcane Supplies For Ethanol
• Will Need To Wait Until August-September To Assess Monsoon Impact
• Govt Encouraging Mills To Start Crushing Early By Approx 15 Days To Release Next Yr Sugar Supply
• There Is Enough Sugar Inventory To Last Till October
• Current Sugar Prices Have Come To A Desired Level Of ₹46/kg
• Margin Expected To Be Stable In Distillery Segment
• PLA Plant Largely On Track, To Be Commissioned In December
• Target 100% Capacity Utilisation In FY28 For PLA Plant

• Horizon Industrial Parks has fixed the price band for its IPO at ₹57-60 per share.
• The public issue will open for subscription on August 17 and close on August 19, while the anchor investor portion will open on August 14.
• Retail investors can bid for a minimum of one lot comprising 250 equity shares and in multiples thereafter. At the upper end of the price band, the minimum investment required will be ₹15,000.
• The Blackstone-backed company aims to raise ₹2,600 crore through the IPO, which comprises entirely a fresh issue of equity shares. There is no offer for sale (OFS) component.
  Read more

Godrej Consumer shares are in focus after the resignation of its MD and CEO Sudhair Sitapati. Meanwhile, brokerage firm HSBC also downgraded its rating on the stock.

Read more here

J&K Bank Board Approves Fund Raise Of Up To ₹1,000 Crore In One Or More Tranches Via QIP

Robert Subbaraman, Nomura On CNBC-TV18

• Outlook For H2 Increasingly Cloudy Due To The Situation Surrounding Around AI
• Nomura View Is That The Indian Economy Will Remain Resilient
• Key Metric To Watch Will Be Core CPI, Expected To Have A Significant Impact On Market
• Remain Constructive & Positive On India
• India Inflation Remains Relatively Benign
• Have Raised FCNR(B) Inflows Expectations To $80-90 Bn
• Currency Is Going To Be Under Pressure

Market Cues for today:

• Underweight, Target Price Rs 9
• IDEA highlighted that it has seen partial success in its fund-raising efforts as it has raised Rs64bn through a combination of Rs11.8bn from part proceeds from issue of warrants to Aditya Birla Group and the remaining Rs52bn through a combination of external commercial borrowings (ECB) and private banks debt funding.
• It reiterated its guidance for capex of Rs450bn over three years and highlighted that it remains in talks with a public sector banks consortium led by SBI as well as private banks and ECB to raise the remaining amount.
• 1Q capex came in below expectations due to supply-side issues stemming from geopolitics, but it has placed capex orders worth Rs90bn including the Rs19bn capex done in 1Q that it expects to execute over the next two quarters
• Increase revenues/cash Ebitda by 1% over FY27-29E mainly due to ARPU change.
• Remain Underweight as believe at 14.8x/12.6x FY27/28E EV/Ebitda, the stock seems to be baking in all positives

• Sell. Target Price Raised to Rs 1040
• EBITDA of Rs18.7bn was 5% ahead of estimates, supported by strong India growth (+19.5% YoY), while Mirabegron revenues remained resilient despite expectations of a decline due to competition.
• Consolidated revenue grew 22% YoY, with acquisitions contributing 12%, implying underlying growth of 10% YoY
• Reported EBITDA margin stood at 23%, while estimate the underlying margin excluding Mirabegron to be 20%
• Management reiterated its FY27E guidance of double-digit revenue growth and ~24% EBITDA margin.

• Outperform, Target Price Rs 1310
• 1Q driven by healthy growth in all segments (ex-US).
• Its margin (in line) was lower primarily due to higher opex from acquisitions.
• It maintained its guidance of strong double-digit revenue growth in FY27 and margin of 24% due to product mix and higher costs related to new launches.
• Zydus expects margins to improve with the ramp up of its branded portfolio
• Raise estimates over FY27-29CL owing to the full impact of the Assertio acquisition and a slew of upcoming launches in the US

• Hold, Target Price Rs 1100
• Healthy revenue growth in 1Q but missed EBITDA margins estimates on higher costs; Zydus retained FY27 guidance
• Think new growth initiatives (e.g. branded products) will build up gradually; watch for execution and cost trends
• FDA approval for saroglitazar magnesium will be the next key event

Jefferies on Zydus Life:

Buy, Target Price Rs 1,370
Delivered an in-line Jun-26Q with continued growth momentum in India and international markets.
US grew 5% QoQ on the back of new launches.
Zydus reiterated its FY27 guidance of DD overall revenue growth, SD US growth and 24% EBITDA margin.
FTF launches, innovative portfolio and strong base to support growth beyond FY27
Cut FY27 EPS by 3% but increase FY28/29 EPS by 5-11% on stronger growth prospects.

Nomura on KEC International:

Neutral, Target Price Rs 495
Lackluster 1Q marks a weak start to FY27
Order pipeline healthy at INR2tn but conversion will be a key monitorable
FY27E revenue growth guidance maintained at 12-15% with pickup likely from 3Q
Trades at 15x FY28F EPS